about
Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): a case control studyPathogenesis of Zika Virus-Associated EmbryopathyComorbidities and Metabolic Derangement of NAFLDEndocrine causes of nonalcoholic fatty liver diseaseThe Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver DiseaseType 2 diabetes as a disease of ectopic fat?Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob miceThe amelioration of hepatic steatosis by thyroid hormone receptor agonists is insufficient to restore insulin sensitivity in ob/ob miceRole of β-adrenergic receptors in regulation of hepatic fat accumulation during agingAggravation of nonalcoholic steatohepatitis by moderate alcohol consumption is associated with decreased SIRT1 activity in ratsSmall molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humansDifferential regulation of PGC-1alpha expression in rat liver and skeletal muscle in response to voluntary runningNon-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Exercise Intensity Modulates Glucose-Stimulated Insulin Secretion when Adjusted for Adipose, Liver and Skeletal Muscle Insulin Resistance.Multiple short bouts of exercise over 12-h period reduce glucose excursions more than an energy-matched single bout of exercise.4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.Longitudinal evaluation of hepatic lipid deposition and composition in ob/ob and ob/+ control mice.Age- and Gender Dependent Liver Fat Content in a Healthy Normal BMI Population as Quantified by Fat-Water Separating DIXON MR ImagingLifestyle intervention involving calorie restriction with or without aerobic exercise training improves liver fat in adults with visceral adiposityCirculating palmitoleate strongly and independently predicts insulin sensitivity in humans.Pathogenesis of non-alcoholic fatty liver disease.Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort studyPPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver DiseaseAssociation of calf circumference with insulin resistance and non-alcohol fatty liver disease: the REACTION studyThe D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: results from the TULIP and METSIM Studies.Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.Pediatric Non-Alcoholic Fatty Liver DiseaseNonalcoholic fatty liver disease and polycystic ovary syndrome.Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI studyNon-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.Nonalcoholic fatty liver disease and the heart in children and adolescents.Plasma fetuin-A concentrations in young and older high- and low-active men.Gender differences in insulin resistance, body composition, and energy balance.Association between noninvasive fibrosis markers and cardio-vascular organ damage among adults with hepatic steatosis.Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signalSubstitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects.Preventing phosphorylation of sterol regulatory element-binding protein 1a by MAP-kinases protects mice from fatty liver and visceral obesity.Relationships of circulating sex hormone-binding globulin with metabolic traits in humans.Association of Alanine Aminotransferase Levels (ALT) with the Hepatic Insulin Resistance Index (HIRI): a cross-sectional study.Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease.
P2860
Q24633948-82E83FCF-FFE6-41F7-9CE0-C7C03C4885F4Q26314595-51519C41-AE0A-42A4-B632-FCC0A89E3D29Q26777147-65D29759-F22C-4295-9350-FD189A00EED3Q26780254-354199EF-F92E-41AF-A7FD-C4C28598D5BEQ26780509-4AA58CF4-240E-4DFB-8C56-451DBC28C3A1Q27022915-61828541-4656-4C71-BD36-40C123871F3FQ28476015-B0EA27BC-726B-45F9-B4A9-5CB1AFF431D9Q28545792-49BDE372-DA18-47EB-9BB5-54572D8F3F6CQ28572834-37A2409B-F592-48C4-A3AD-0F3196EEBBF4Q28573665-B32C43EF-FF91-4DB8-97A8-1E3DB0D38DBFQ28576077-2DE2F11F-402B-4793-945C-A134E95C73D8Q28583037-E65B82C4-D5FD-4BD3-8EF8-1D405CDC14FDQ30235846-71FB82AD-5FAD-4038-96CF-D4DC27531C1DQ30276917-BBA353CC-28F9-47A0-92B6-AF72FB66975FQ30406136-3D01D2BE-EC7B-4C5E-A0E3-11E6B0DBBF83Q30412771-4CEEF656-8BA5-44A0-BE0A-9A44BED032DAQ30586373-C6D90175-68BA-4242-BC1F-A9F63B967EC5Q31020766-C7561450-434B-49AE-8E79-E432ABCA90F1Q33594330-CAB6A161-E3E6-40F7-AA18-808CD7E96362Q33602334-2BF7EF9A-2EA0-4191-88DC-6531BFA61E52Q33606303-C2706B10-AAEA-446B-8CF8-869745BD8AC5Q33644131-9954C670-7E32-4F23-80C9-3EE1FD793001Q33734125-5F19552A-1D05-4771-986E-B4C9AFA6A5ADQ33742855-11EFC207-74B6-49DB-9725-7B6606A8F957Q33761411-392139DB-8763-4C30-B4DA-CA19DC3F6380Q33777486-A07A599A-551E-4C9F-BD4A-6AEAF80E9C0BQ33831717-E1C0CC30-D789-44CD-977E-CD5B70F86FEAQ33886930-E62A7E28-F67B-4138-A008-AD157E18F7AEQ33926100-55E7B3D8-AEE5-4E13-A885-2EFA708EB2B5Q33948324-595BC7A8-CE8A-419F-9CCF-F689319896E6Q33958722-F71235AD-625B-4187-9C89-1EB443E56856Q33976378-0BA0DB21-394D-42B4-9473-B429B8537CD6Q34013754-4475CBC7-2FCB-4A00-8142-21B5C2F8F886Q34027919-F364733D-AAFA-4844-8CC7-F755F1CEC7CAQ34098522-71EC17A5-9225-49B2-A644-95C746D4B232Q34126000-DA666884-9930-4348-ABB0-41DB354B9EDBQ34182797-5C00E24C-C146-4CD6-9F9D-E740ECB602F1Q34355301-DC364419-3A76-4488-89E7-C4A84C17D34EQ34402713-2F79251D-DF04-4452-87D4-FC2A2361F73DQ34419171-625F47F0-95BA-4672-B804-10AB7A058D95
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Causes and metabolic consequences of Fatty liver.
@en
Causes and metabolic consequences of Fatty liver.
@nl
type
label
Causes and metabolic consequences of Fatty liver.
@en
Causes and metabolic consequences of Fatty liver.
@nl
prefLabel
Causes and metabolic consequences of Fatty liver.
@en
Causes and metabolic consequences of Fatty liver.
@nl
P356
P1433
P1476
Causes and metabolic consequences of Fatty liver.
@en
P2093
Konstantinos Kantartzis
P304
P356
10.1210/ER.2008-0009
P577
2008-08-21T00:00:00Z